51 results
8-K
EX-99.1
ACET
Adicet Bio Inc
14 May 24
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
4:03pm
in lupus nephritis in 2Q 2024
Presented promising preclinical data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
8-K
ACET
Adicet Bio Inc
10 May 24
Regulation FD Disclosure
6:09am
of the American Society of Gene and Cell Therapy (ASGCT ) The Company’s presentation was posted to the “Presentations & Events” section of the Company’s
8-K
ACET
Adicet Bio Inc
22 Apr 24
Regulation FD Disclosure
4:31pm
Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th
8-K
EX-99.1
ACET
Adicet Bio Inc
22 Apr 24
Regulation FD Disclosure
4:31pm
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy
8-K
EX-99.1
lrmtox
19 Mar 24
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
4:13pm
8-K
EX-99.1
2a1w1yt3o9m18a
16 Jan 24
Regulation FD Disclosure
7:01am
8-K
EX-99.1
gq6w4 9w0
8 Nov 23
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:12pm
8-K
EX-99.1
r5js91qicesi
9 Aug 23
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:17pm
8-K
EX-99.1
t94a4ewqhzy5tmfyg5x
26 Jun 23
Regulation FD Disclosure
4:02pm
8-K
05xhx0ssw8 xp
26 Jun 23
Regulation FD Disclosure
4:02pm
8-K
gtebs
18 May 23
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
6:02am
8-K
EX-99.1
awdp6 sckj9jhrz
18 May 23
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
6:02am
8-K
EX-99.1
kd3ei
9 May 23
Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates
4:14pm
8-K
aw3pkjscm
12 Dec 22
Regulation FD Disclosure
6:03am
8-K
EX-99.1
bth4ayt65eiiwv3y1w
12 Dec 22
Regulation FD Disclosure
6:03am
424B5
tstw3n
8 Nov 22
Prospectus supplement for primary offering
5:23pm
8-K
EX-99.1
c77 uopj8s
8 Nov 22
Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates
4:13pm